Ark Genomic Revolution ETF (ARKG) closed at $48.25 on November 9, 2026, up 6.2% from the previous close, on volume of 3,621,881 shares (30-day average 5,565,539).
Data as of November 9, 2026.
9-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 15, 2026 | Jelly Roll or Diagonal Double Straddle | 16-Oct-2645 P : 45 C|20-Nov-2650 P : 50 C | 140,000 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
No press releases found.
Cathie Wood's Ark Invest buys $96M of SpaceX, adds to Nvidia and AMD; trims Broadcom
Seeking Alpha News (Mon, 9-Nov 7:05 AM ET)
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer discretionary, that are relevant to the Fund's investment theme of the genomics revolution. Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. The companies held in ARKG may be leaders, enablers, or beneficiaries of technologies.
Ark Genomic Revolution ETF trades on the ARCA stock market under the symbol ARKG.
As of November 9, 2026, ARKG stock price climbed to $48.25 with 3,621,881 million shares trading.
ARKG has a beta of 1.58, meaning it tends to be more sensitive to market movements. ARKG has a correlation of 0.18 to the broad based SPY ETF.
ARKG has a market cap of $2.08 billion. This is considered a Mid Cap stock.
In the last 3 years, ARKG traded as high as $58.83 and as low as $17.51.
ARKG has outperformed the market in the last year with a price return of +70.1% while the SPY ETF gained +13.4%. ARKG has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +19.0% and +0.2%, respectively, while the SPY returned -1.8% and -1.0%, respectively.
ARKG support price is $43.66 and resistance is $47.24 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARKG shares will trade within this expected range on the day.
